Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01324622
Other study ID # 2442
Secondary ID
Status Terminated
Phase N/A
First received March 23, 2011
Last updated November 3, 2017
Start date January 1, 2006
Est. completion date November 1, 2010

Study information

Verified date October 2017
Source Synthes USA HQ, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this study is to compare the clinical and radiographic outcomes of multi-level laminectomy to multi-level laminoplasty in the treatment of patients with cervical myelopathy or myeloradiculopathy. The hypothesis for the study is that the laminoplasty group is not inferior to the laminectomy group.


Description:

Historically, cervical laminectomy has been proven to be effective in the treatment of symptomatic patients with cervical myelopathy. This standard procedure is employed to accomplish posterior decompression of the cervical spinal cord in patients with multi-level cervical spinal stenosis who have normal or near normal cervical spinal curvature and alignment without associated instability. Laminoplasty was developed in Japan as an alternative to the laminectomy procedure with the intent to reduce post-operative morbidity after dorsal cervical spinal cord decompression, neck pain and to maintain the relative stability of the cervical spine after multi-level decompression.

The goal of both the laminoplasty and laminectomy procedures is to provide spinal cord decompression by enlargement of the spinal canal. A potential benefit of laminoplasty compared to laminectomy is to preserve stability and range of motion of the cervical spine without complete disruption/removal of the posterior laminae, spinous processes and interspinous ligamentous structures. Various authors have described different laminoplasty techniques; all preserve the lamina and expand the size of the spinal canal by fixing the freed or partially freed lamina in a more posterior position.

The primary study hypothesis is that, patients treated with laminoplasty with ARCH fixation (Treatment Group) have clinical and radiographic outcomes as assessed by valid outcomes measures, is not inferior to patients treated with laminectomy (Control Group)


Recruitment information / eligibility

Status Terminated
Enrollment 24
Est. completion date November 1, 2010
Est. primary completion date November 1, 2010
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: All must be met for inclusion in the study.

- The patient must be at least 18 years of age and have no evidence of developmental anomaly of the cranial cervical junction and/or cervical spine

- The patient has the diagnosis of cervical myelopathy

- The myelopathy or myeloradiculopathy requires a posterior cervical decompression of the spinal canal involving two or more contiguous intervertebral levels including and between C3 and C7

- The patient signs the study informed consent form.

Exclusion Criteria:

- Primary symptoms and signs of cervical radiculopathy (only) without myelopathy.

- Presence of primary focal anterior compression of the cervical spinal cord.

- Ossification of the ligamentum flavum.

- Previous surgery of the cervical spine.

- Tumor, infection, or trauma of the cervical spine or cord.

- Segmental instability - Pregnant or interested in becoming pregnant during the study follow-up period.

- Known sensitivity to device materials.

- Currently being treated or intends to be treated postoperatively with other devices for the same disorder (e.g., electrical stimulation devices, pain control devices, etc.).

- Currently a participant in any other study related to the treatment of cervical spinal disorders.

- Prisoner

- Mentally incompetent, or unable to comply with the follow up regime

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Laminoplasty
Utilizing the ARCH Fixation System (Study device)
Procedure:
laminectomy
standard procedure

Locations

Country Name City State
United States Tower Orthopaedics Beverly Hills California
United States Research Medical Center Kansas City Missouri
United States Yale University School of Medicine New Haven Connecticut
United States Washington University School of Medicine Saint Louis Missouri

Sponsors (1)

Lead Sponsor Collaborator
Synthes USA HQ, Inc.

Country where clinical trial is conducted

United States, 

References & Publications (1)

Edwards CC 2nd, Riew KD, Anderson PA, Hilibrand AS, Vaccaro AF. Cervical myelopathy. current diagnostic and treatment strategies. Spine J. 2003 Jan-Feb;3(1):68-81. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Imrovement in Modified Japanese Orthopaedic Assessment (mJOA) Recovery Rate Number of participants who have mJOA Recovery Rate =0%. mJOA Recovery Rate is defined as: mJOA Recovery Rate = ((PostOp Score-PreOp Score)/(17 - Pre-Op Score))*100 12 months
Primary Sagittal Angle Success Success defined as = +15º (kyphosis) as indicated by a neutral lateral radiograph 12 months
Primary Incidence of Surgical Interventions Success defined as a lack of revision, removal or addition of supplemental fixation. up to 24 months
Secondary Pain Scores on the Visual Analog Scale Up to 24 months
Secondary Functional Improvement Using the Neck Disability Index (NDI) up to 24 months
Secondary Quality of Life Improvement Using the SF-12 Scale up to 24 months
Secondary Motor Deficit up to 24 months
Secondary Reflex Evaluation up to 24 months
Secondary Sensory Deficit up to 24 months
Secondary Range of Motion up to 24 months
Secondary Sagittal Canal Diameter up to 24 months
Secondary Extent of Spinal Canal/Cord Decompression up to 24 months
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05506657 - Early Intervention to Promote Return to Work for People With Spinal Cord Injury N/A
Completed NCT00116337 - Spinal Cord Stimulation to Restore Cough N/A
Completed NCT01202227 - An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic Pain Phase 3
Completed NCT00447343 - Reorganization of Brain Functions in Patients With Cervical Myelopathy Using fMRI and MRS N/A
Recruiting NCT05023772 - Laser Interstitial Thermal Ablation and Stereotactic Radiosurgery for Patients With Spine Metastases N/A
Completed NCT00995215 - Sub-study to Spinal Cord Stimulation to Restore Cough N/A
Enrolling by invitation NCT04101916 - PAS in Subacute SCI N/A
Not yet recruiting NCT05508802 - Interventional Cooperative Agreement Program - Vocational Intervention Demonstration N/A
Completed NCT04683471 - Pilot Trial of a System for Motor Function Recovery N/A
Recruiting NCT05589415 - Targeted HD-tDCS to Improve Upper Limb Rehabilitation in SCI N/A
Completed NCT01495390 - A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers N/A
Completed NCT05659121 - Improving Mobility Via Robotic Exoskeletons in Local Rehabilitation Settings in Singapore N/A
Terminated NCT04265560 - Progressive Resistance Training in Acute Spinal Cord Injury N/A
Recruiting NCT05725499 - The Effect of Transcutaneous Stimulation on Blood Pressure in Spinal Cord Injury (SCI) N/A
Completed NCT03104803 - Long-term Paired Associative Stimulation as a Treatment for Incomplete Spinal Cord Injury of Non-traumatic Origin N/A
Completed NCT00629642 - Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis Phase 4
Recruiting NCT06302478 - 5E Program for Preventing Venous Thromboembolism in Patients With Spinal Cord Disorders N/A
Recruiting NCT04827095 - Comparison of Two Web-Based Education/Support Programs for Partner Caregivers of People With Spinal Cord Injury N/A
Active, not recruiting NCT03534518 - Body Weight Supported Training Study N/A
Enrolling by invitation NCT05994846 - Non-Invasive Electrical and Magnetic Neuromodulation in Persons With Chronic Spinal N/A